# Conlight Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/conlight-medical

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.kanglijianyan.com
- Latest round: Series A (Mar 26, 2021)
- Investors on record: 2

## About

Established in 2015 and based in Shanghai, China, Conlight Medical is a provider of genetic testing services, a qualified third party independent laboratory and a GMP factory.

The company’s main businesses include: molecular diagnosis, gene targeted diagnosis, pharmaceutical manufacturing, medical services, high-end health management and promotion, etc. Conlight Medical focuses on the research of pharmacogenomics and metabonomics and is committed to promoting its clinical transformation and application. At the same time, Conlight Medical is the first company to conduct drug gene testing in psychiatric department and has the largest database. At present, it has accumulated more than 100,000 drug-related gene mutation sites and clinical research data with high research value. We provide ovarian cancer susceptibility gene risk assessment, prostate cancer gene risk assessment, gallstone gene risk assessment, breast milk basic nutrition testing, human amino acid testing and other services for women, men, middle-aged and elderly people, maternal and infant populations, and functional medicine. So far, data of drug-related gene mutation sites and clinical studies with high research value have been accumulated for the Chinese population.

## Funding rounds

- Series A, Mar 26, 2021 — Nantong Zhineng Private Equity Fund Management
- Series A, Mar 18, 2019 — Qiaojing Capital

## Investors

- Qiaojing Capital (https://capitalatlas.ai/funds/qiaojing-capital) — Series A
- Nantong Zhineng Private Equity Fund Management (https://capitalatlas.ai/funds/nantong-zhineng-private-equity-fund-management) — Series A